-
3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Fermentation API, Contract Pharma and OTC Stocks with a strong future roadmap: Concord Biotech, Laurus Labs and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals
- October 26, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
API, Excipient and Generic Pharma Stocks with a strong future roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Finished Dosage Generics, Anti-Retroviral and Active Ingredient Leader and Complex Oncology Generics Stocks With a Strong Future Roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma
- October 23, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
US Generics and Complex Oncology Drug Stocks with a strong future roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Chronic Therapy Brands, Biotech Development Services and Ingredients and Formulations Stocks With a Strong Future Roadmap: Eris Lifesciences, Anthem Biosciences and Laurus Labs
- October 22, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Domestic Brand and Biotech Outsourcing Stocks with a strong future roadmap: Eris Lifesciences, Anthem Biosciences and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Global Pharma Franchise, Sterile Injectables and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: Lupin, Gland Pharma and Laurus Labs
- October 22, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Export-focused Pharma Stocks with a strong future roadmap: Lupin, Gland Pharma and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Domestic Brands, Anti-Malarial Leader and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Ipca Laboratories and Laurus Labs
- October 22, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Branded and API Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Ipca Laboratories and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Anti-Retroviral Ingredients, Paracetamol Dosages and Specialty Formulations Stocks With a Strong Future Roadmap: Laurus Labs, Granules India and Rubicon Research
- October 21, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
API and Formulation Maker Stocks with a strong future roadmap: Laurus Labs, Granules India and Rubicon Research. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 CDMO Stocks With a Strong Future Roadmap: Divi’s Laboratories, Laurus Labs and Neuland Laboratories
- October 6, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Divi’s Laboratories, Laurus Labs and Neuland Laboratories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.